Survival analysis of the 52 core target genes showed that HSPB1, COL3A1, SPP1, OLR1, IGFBP3 and TGFB1 were associated with adverse prognosis of the 214 GEO CRC patients. The gene discussed is IGFBP3; the disease is colorectal carcinoma.